[Note: The company’s name was officially changed March 31, 2021 to Astellas Gene Therapies.] Audentes Therapeutics, a San Francisco gene therapy company, is joining other leaders in the highly specialized field by sticking a manufacturing sword in North Carolina soil. Audentes, which was purchased in January by Tokyo-based Astellas Pharma Inc., will establish a $109.4… Read more »